Evaluation of tumor response to antiangiogenic therapy in patients with recurrent gliomas using contrast-enhanced perfusion-weighted magnetic resonance imaging techniques: A meta-analysis

Table 3 Clinical responses of gliomas to antiangiogenic treatments

Study	Patient, n	RANO criteria				Macdonald criteria
		Responders		Non-responders		Responders		Non-responders
		CR	PR	SD	PD	CR	PR	SD	PD
O’Neill et al[32], 2016	12	-	-	-	-	0	1	0	11
Piludu et al[30], 2015	27	0	6	5	16	-	-	-	-
Schmainda et al[4], 2014	36	0	6	0	30	-	-	-	-
Iwamoto et al[29], 2010	11	-	-	-	-	0	1	6	4
Hilario et al[33], 2016	24	0	14	0	10	-	-	-	-
Kalpathy-Cramer et al[31], 2017	10	1	1	4	4	-	-	-	-

CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease. *Response as defined using the Macdonald criteria and Response Assessment in Neuro-Oncology (RANO) working group guidelines.